Exchange: OTC·Updated 02:42 PM EDT

GNTLF Genetic Technologies Ltd.

$0.00
$0.00
(0.00%)
Today
EarningsFeb 25
Mkt Cap$1,300.00
Vol2,000.00

About GNTLF

Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. It operates through the following segments: EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment focuses on EasyDNA branded test sales and expenses. The AffinityDNA segment deals with AffinityDNA branded test sales and expenses. The GeneType/Corporate segment includes the GeneType branded test sales and expenses, including corporate charges. The company was founded on January 5, 1987, and is headquartered in Maroochydore, Australia.
50

Neutral Sentiment

How do you feel about GNTLF?

Advertisement|Remove ads.